Home
About
Overview
Sharing Data
ORCID
Help
History (6)
Nitrosative Stress
Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness.
The importance of initial heparin treatment on long-term clinical outcomes of antithrombotic therapy. The emerging theme of delayed recurrence.
Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
Apixaban versus enoxaparin for thromboprophylaxis after hip replacement.
See All 6 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Apixaban versus enoxaparin for thromboprophylaxis after hip replacement.
Apixaban versus enoxaparin for thromboprophylaxis after hip replacement. N Engl J Med. 2010 Dec 23; 363(26):2487-98.
View in:
PubMed
subject areas
Administration, Oral
Adult
Aged
Aged, 80 and over
Anticoagulants
Arthroplasty, Replacement, Hip
Confidence Intervals
Double-Blind Method
Enoxaparin
Factor Xa Inhibitors
Female
Hemorrhage
Humans
Injections, Subcutaneous
Male
Middle Aged
Postoperative Complications
Pyrazoles
Pyridones
Treatment Outcome
Venous Thromboembolism
Young Adult
authors with profiles
Gary E Raskob